IBSA USA
Elena Schwem is a seasoned sales professional with extensive experience in the healthcare sector. Currently serving as a Field Sales Representative at IBSA USA since October 2022, Elena has previously held positions as a Clinical Sales Specialist at Syneos Health, a Wound Care Specialist at Stratpharma, and a Territory Sales Manager at Mission Pharmacal, where notable achievements include launching multiple products and achieving top sales rankings. Early career experience also includes a role as a Diabetes Therapy Associate at Medtronic, marked by exceptional sales performance and recognition as a top performer. Elena holds a BBA in Management and International Business from The University of Texas at San Antonio.
This person is not in the org chart
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.